AstraZeneca announced a trial date has been set for patent litigation in the US District Court for the District of New Jersey against Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging inf
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
AstraZeneca announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceuti
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
AstraZeneca has announced its submission of SEROQUEL XR (quetiapine fumarate extended release tablets) to European regulatory authorities seeking approval for both short-term and maintenance treatmen
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
AstraZeneca has announced that the once-daily formulation SEROQUEL XR (quetiapine fumarate extended release tablets) and SEROQUEL (quetiapine fumarate) have been approved under the European Mutual Re
read more » Discuss Add this link to...Bury Add to:
| Bookmarks